Wordt geladen...
Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 diabetes (T2D) or cardiovascular diseases (CVD). Extra...
Bewaard in:
| Gepubliceerd in: | Obes Med |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier Ltd.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785422/ https://ncbi.nlm.nih.gov/pubmed/33426364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.obmed.2020.100312 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|